Strides Pharma Science share news, announcements and annual reports
NSE: STARBSE: 532531Pharmaceuticals & BiotechnologySmall Cap
Strides Pharma Science Limited · Formerly Strides Shasun · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000 on NSE, Jun 2004 on BSE
Last close ₹1,036.90down ₹31.90 (2.98%)BSE ₹1,037.80
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,068.80.
2 Nov: open ₹1,067.30, high ₹1,067.30, low ₹1,013.90
52-week range of traded prices to 2 Nov 2026
₹768.65Low, 29 Jan 2026₹1,260.90High, 21 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,557 Cr580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.50
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.80
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.48%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.53
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,07,98637.7% delivered
Strides Pharma Science orders, deals and press releases
485 filed, newest first. Page 9 of 10.
Jun 2010
May 2010
26 May · Business
Company has allotted 10,000 fully paid equity shares of Rs. 10/- each under Strides Acrolab ESOP 2008 (Director) Scheme to a Director of the Company. Consequent to the allotment, the paid up Equity share capital of the Company has increased from Rs. 435,291,380 consisting of 43,529,138 equity shares of Rs. 10/- each to Rs. 435,391,380 consisting of 43,539,138 equity shares of Rs. 10/- each.
Apr 2010
22 Apr · Business
Press release dated April 22, 2010 titled "Strides today announced Q1'10 financials; Delivers strong growth and Performance is in line with guidance". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Apr · Business
Press release dated April 22, 2010, titled "Strides Arcolab Announces US FDA Tentative Approval of Additional Adenosine Injection; Approval Momentum Continues - Total Approvals in Sterile Space at 23". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Apr · Business
Press release dated April 21, 2010 , titled "Strides Arcolab Announces USFDA Approval For Metoprolol Tartrate Injection; Approval Momentum Continues - Total Approvals in Sterile Space AT 22". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Apr · Business
Press release dated April 20, 2010 , titled "Strides redeems USD 34 Million FCCBs due 2010". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Apr · Business
Press release dated April 19, 2010, titled "Strides Arcolab announces USFDA approval for Mesna Injection- Total Approvals In Sterile Space At 21". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Apr · Business
Press release dated April 14, 2010, titled "Strides Arcolab announces USFDA approval for Granisetron Hydrochloride Injection - Total Approvals in Sterile Space at 20". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2010
18 Mar · Business
Press release dated March 18, 2010, titled "Strides revises guidance upwards for FY 2010 ; Post Oncology and Campos transactions with Aspen". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Mar · Business
Press release dated March 18, 2010, titled "Strides and Aspen restructure Oncology arrangements, Strides to acquire 100% interest in Oncology JVs". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Mar · Business
Press release dated March 16, 2010, titled "Proposal for Acquisition of Minority Shares in Ascent Pharmahealth Ltd ". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Mar · Business
Press release dated March 04, 2010, titled " Strides to acquire Campos facility in Brazil from Aspen". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2010
24 Feb · Business
Press release dated February 24, 2010 with respect to the Audited Financial Results for the year ended December 31, 2009. Further the Company has submitted a copy of Results Pack Financials for the year 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Feb · Business
Press release dated February 09, 2010, titled "Strides Arcolab Announces USFDA Approval For Labetalol Hydrochloride Injection, USP - Total Approvals in Sterile Space at 18." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
20 Jan · Business
Mr. V. S. Iyer has been appointed as an Executive Director of the Company effective January 19, 2010. Further the Company has submitted a copy of press release on this regard. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Jan · Business
Press release dated January 06, 2010, titled "Pfizer and Strides Arcolab to Collaborate on Generic Products." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2009
11 Dec · Business
Press release dated December 11, 2009, titled " Strides Arcolab Announces Conclusion of Court Process for Merger." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
30 Oct · Business
Press release dated October 30, 2009, titled "Financial Performance Q3-2009; Revenue up by 17%; EBITDA up by 134%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
25 Sep · Business
Press release dated September 25, 2009, titled "Strides Arcolab announces the retail launch of Starflu (OSELTAMIVIR) for the treatment of 'Influenza - A (H1N1)'". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Sep · Business
Press release dated September 01, 2009, titled "Strides Arcolab Limited receives order from Government of India for the supply of Oseltamivir Capsules for the treatment of 'Influenza-A (H1N1)' ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
11 Aug · Business
Press release dated August 11, 2009, titled "Strides Arcolab Limited Fully geared to meet demand for supply of drugs for Influenza - A (H1N1) Pandemic". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
30 Jul · Business
Press release dated July 30, 2009 titled "Financial Performance Q2-2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements. For more details click here.
Jun 2009
24 Jun · Business
The Equity Shareholders of the Company at their meeting convened as per the order of the Hon'ble High Court of Judicature at Bombay, held on June 24, 2009 have approved the Scheme of Arrangement between Grandix Pharmaceuticals Limited, Grandix Laboratories Limited, Global Remedies Limited and Quantum Remedies Private Limited ('Transferor Companies') with Strides Arcolab Limited (Transferee Company)
May 2009
15 May · Business
Press release dated May 15, 2009 titled "Strides Arcolab announces 2 ANDA approvals for Adenosine Injection USP and Meloxicam Tablets USP-Total approvals in Steriles space at 16 and Orals space at 12". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements. For more details click here.5 May · Business
Press release titled "Strides Arcolab Commences commercial supplies of Oseltamivir Capsules For Influenza-A(H1N1) Virus (Swine Flu)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements. For more details click here.
Apr 2009
24 Apr · Business
Press release dated April 24, 2009 titled "Financial Performance Q1-2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements For more details click here.13 Apr · Business
Press release dated April 13, 2009, titled "Strides Arcolab to align its Global Operations into 3 Separate entities Specialty Pharmaceuticals, Pharmaceuticals & R&D". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Apr · Business
Press release dated April 08, 2009, titled "Strides Arcolab receives NDA approval from USFDA for Lamivudine and Stavudine under PEPFAR scheme Total PEPFAR approvals- 11". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2009
27 Mar · Business
Press release dated March 27, 2009 titled "Strides Arcolab announces USFDA approval for one more product - Takes total sterile product approvals to 15 - First product approval for Strides Sagent JV." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements. For more details click here.18 Mar · Business
Press release dated March 18, 2009 titled "Strides Receives USFDA Inspection Approval Status for its Steriles Injectable Complex 'Zero 483's Status'." . A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements. For more details click here.
Feb 2009
26 Feb · Business
Press release dated February 25, 2009 with respect to the Audited financial results for the year ended December 31, 2008. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements For more details click here.
Jan 2009
5 Jan · Business
Press release dated January 05, 2009, titled "Balachandar to lead Human Resources at Strides". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Jan · Business
Press release dated January 02, 2009, titled "Strides Arcolab receives USFDA approval for two more products -Takes total Sterile product approvals to 14". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2008
3 Nov · Business
Press release dated November 03, 2008, titled "Strides Arcolab receives USFDA approval for one more product - Takes total Sterile product approvals to 12". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
31 Oct · Business
Press release dated October 31, 2008, titled "Q3'08 Revenue up 32% to Rs. 282 Cr.; Operational EBITDA at Rs. 36.7 Cr. Up 128%; PAT at Rs. 105.40 Cr". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Oct · Business
Press release dated October 07, 2008, titled "Strides Arcolab Receives USFDA Approval For Its Oral Dosage Form Facility, Bangalore". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
16 Sep · Business
Press release dated September 16, 2008, titled "Strides Completes Business Rearrangement; Consolidates Steps to Profitable Growth". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Sep · Business
Press release dated September 02, 2008, titled "Strides Arcolab receives USFDA approval for two more products - Takes total Sterile product approvals to 11". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements For more details click here.
Aug 2008
1 Aug · Business
Press release dated August 01, 2008, titled "Strides completes acquisition of controlling interest in Ascent Pharmahealth Limited (formely Genepharm Australasia Limited). Emerges as Australia's 4th largest Generic Company . Australasia becomes USD 90 Million operation for Strides". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
23 Jul · Business
Press release dated July 23, 2008, titled "Strides/Aspen Joint Venture; In-Licensing Deal with GSK". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jul · Business
Press release dated July 22, 2008, titled "Q2'08 Revenue up - 49% to Rs. 269 Cr.; EBITDA at Rs. 55 Cr. - Up 176%; PAT Impacted by Exceptional items". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2008
26 Jun · Business
Press release dated June 26, 2008, titled "Strides Arcolab receives ANDA approvals for Famotidine Injection USP 10 mg/ml-2mL and 4mL & 20mL". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2008
23 May · Business
Press release dated May 23, 2008, titled "Strides Arcolab receives ANDA approval for Rifampicin for Injection USP, 600 mg/ vial". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 May · Business
Press release dated May 14, 2008, titled "Strides Arcolab receives ANDA approval for Flumazenil Injections USP, 0.1 mg/ml multiple dose vial". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
30 Apr · Business
Press release dated April 30, 2008, titled "Strides & Genepharm signs definitive agreements-Update on final transaction terms". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.